MRI measurements of aortic arch pulse wave velocity allow physicians to predict cognitive decline and cardiovascular diseases.
Aortic arch pulse wave velocity, measured by phase-contrast MRI, provides a highly significant independent predictor of white matter hyperintensity volume, which can indicate cerebral microvascular disease, according to a study published in the journal Radiology.
Researchers from UT Southwestern Medical Center in Dallas evaluated the relationship between aortic stiffness and cerebrovascular disease in 1,270 participants who were part of the multiethnic Dallas Heart Study. The researchers measured the aortic pulse wave velocity with phase-contrast MRI.
Seven years later, the subjects underwent MRIs to measure the volume of any white matter hyperintensity in the brain. The researchers also looked at 15 other cardiovascular risk factors as predictors of white matter hyperintensity, as well as age, gender, and ethnicities.
The authors found that the aortic arch pulse wave velocity helped predict white matter hyperintensity volume independent of the other demographic and cardiovascular risk factors. They estimated that a 1 percent increase in aortic arch pulse wave velocity (meters per second) is related to a 0.3 percent increase in subsequent white matter hyperintensity volume in milliliters, when all other variables are constant.
The authors concluded that the aortic arch pulse wave velocity measured with phase-contrast MRI is an optimal predictive model of subsequent white matter hyperintensity burden, which in turn can predict cardiovascular disease. These measurements provide a distinct contribution along with systolic blood pressure, hypertension treatment, congestive heart failure, and age.
Diffusion-Weighted MRI and Neoadjuvant Chemotherapy for Rectal Cancer: What New Research Reveals
September 3rd 2024In a comparison of imaging assessments to gauge the effectiveness of neoadjuvant chemotherapy for rectal adenocarcinoma, researchers found the combination of diffusion-weighted imaging and MR tumor regression grading had a 90 percent area under the curve (AUC) and a negative predictive value (NPV) of 93 percent.
New Research Highlights Emerging MRI Contrast Agent for Bladder Imaging
August 21st 2024A new MRI contrast agent may provide a viable non-invasive alternative for the detection of interstitial cystitis, according to preliminary research presented at the 5th International Consultation on Interstitial Cystitis Japan (ICICJ) in Kyoto, Japan.
MRI Study Offers Insights on Traumatic Brain Injury and Cerebral Microbleeds
August 19th 2024Detecting cerebral microbleed (CMB) in one of six healthy adults in a new study, researchers also found that CMB was the only MRI marker of small vessel disease (SVD) to be significantly associated with traumatic brain injury (TBI).